442899867	442899867	CD	B-NP	O
|	|	NN	I-NP	O
CHMC	CHMC	NN	I-NP	O
|	|	NN	I-NP	O
97792290	97792290	CD	I-NP	O
|	|	NN	I-NP	O
|	|	NN	I-NP	O
0998217	0998217	CD	B-NP	O
|	|	CC	I-NP	O
6/26/2006	6/26/2006	CD	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
AM	AM	VBP	B-VP	O
|	|	JJ	B-NP	B-protein
Vertiginous	Vertiginous	JJ	I-NP	I-protein
fall	fall	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
|	|	NN	I-NP	I-protein
DIS	DIS	NNP	I-NP	I-protein
|	|	NNP	I-NP	I-protein
Admission	Admission	NNP	I-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
6/26/2006	6/26/2006	CD	B-NP	O
Report	Report	NNP	I-NP	O
Status	Status	NNP	I-NP	O
:	:	:	O	O
Discharge	Discharge	NNP	B-NP	O
Date	Date	NNP	I-NP	O
:	:	:	O	O
10/24/2006	10/24/2006	CD	B-NP	O
******	******	SYM	I-NP	O
FINAL	FINAL	NN	I-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	O	O
BUTTS	BUTTS	NNP	B-NP	O
,	,	,	O	O
DOMINGO	DOMINGO	NNP	B-NP	O
D	D	NNP	I-NP	O
012-36-26-1	012-36-26-1	CD	I-NP	O
Arv	Arv	NNP	I-NP	O
West	West	NNP	I-NP	O
Wa	Wa	NNP	I-NP	O
Service	Service	NNP	I-NP	O
:	:	:	O	O
MED	MED	NNP	B-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
PATIENT	PATIENT	NNP	I-NP	O
ON	ON	NNP	I-NP	O
:	:	:	O	O
10/26/06	10/26/06	CD	B-NP	O
AT	AT	NN	I-NP	O
01	01	CD	I-NP	O
:	:	:	O	O
00	00	CD	B-NP	O
PM	PM	NNP	I-NP	O
CONTINGENT	CONTINGENT	NNP	I-NP	O
UPON	UPON	NNP	I-NP	O
SNF/rehab	SNF/rehab	NNP	I-NP	O
WILL	WILL	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
ORDER	ORDER	NNP	I-NP	O
BE	BE	NNP	I-NP	O
USED	USED	NNP	I-NP	O
AS	AS	NNP	I-NP	O
THE	THE	NNP	I-NP	O
D/C	D/C	NNP	I-NP	O
SUMMARY	SUMMARY	NNP	I-NP	O
:	:	:	O	O
YES	YES	NNP	B-NP	O
Attending	Attending	NNP	I-NP	O
:	:	:	O	O
BRANDLE	BRANDLE	NNP	B-NP	O
,	,	,	O	O
THOMAS	THOMAS	NNP	B-NP	O
J.	J.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
,	,	,	O	O
M.P.H.	M.P.H.	NNP	B-NP	O
CODE	CODE	NNP	I-NP	O
STATUS	STATUS	NNP	I-NP	O
:	:	:	O	O
Full	Full	JJ	B-NP	O
code	code	NN	I-NP	O
DISPOSITION	DISPOSITION	NN	I-NP	O
:	:	:	O	O
Rehabilitation	Rehabilitation	NN	B-NP	O
DISCHARGE	DISCHARGE	NN	I-NP	O
MEDICATIONS	MEDICATIONS	NNS	I-NP	O
:	:	:	O	O
ACETYLSALICYLIC	ACETYLSALICYLIC	NN	B-NP	B-protein
ACID	ACID	NN	I-NP	I-protein
325	325	CD	B-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
ATENOLOL	ATENOLOL	NNP	I-NP	I-protein
50	50	CD	I-NP	I-protein
MG	MG	NNP	I-NP	I-protein
PO	PO	NNP	I-NP	I-protein
DAILY	DAILY	NNP	I-NP	I-protein
HOLD	HOLD	NN	I-NP	I-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
,	,	,	O	O
l	l	NN	B-NP	B-protein
HR	HR	NN	I-NP	I-protein
<	<	SYM	B-NP	I-protein
60	60	CD	B-NP	I-protein
CIPROFLOXACIN	CIPROFLOXACIN	NN	I-NP	I-protein
500	500	CD	B-NP	I-protein
MG	MG	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
Q12H	Q12H	NN	I-NP	I-protein
X	X	SYM	B-VP	I-protein
12	12	CD	B-NP	I-protein
doses	dose	NNS	I-NP	I-protein
Food/Drug	Food/Drug	NNP	B-NP	I-protein
Interaction	Interaction	NNP	I-NP	I-protein
Instruction	Instruction	NNP	I-NP	I-protein
Administer	Administer	NNP	I-NP	I-protein
iron	iron	NN	I-NP	I-protein
products	product	NNS	I-NP	I-protein
a	a	DT	B-NP	O
minimum	minimum	NN	I-NP	O
of	of	IN	B-PP	O
2	2	CD	B-NP	O
hours	hour	NNS	I-NP	O
before	before	IN	B-PP	O
or	or	CC	I-PP	O
after	after	IN	I-PP	O
a	a	DT	B-NP	O
levofloxacin	levofloxacin	NN	I-NP	O
or	or	CC	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
dose	dose	NN	I-NP	O
dose	dose	NN	I-NP	O
If	If	IN	B-SBAR	O
on	on	IN	B-PP	O
tube	tube	NN	B-NP	O
feeds	feed	NNS	I-NP	O
,	,	,	O	O
please	please	VB	B-VP	O
cycle	cycle	NN	B-NP	B-protein
-LRB-	-LRB-	NN	I-NP	I-protein
hold	hold	VBP	B-VP	O
1	1	CD	B-NP	O
hr	hr	NN	I-NP	O
before	before	IN	B-PP	O
to	to	TO	B-PP	O
2	2	CD	B-NP	O
hr	hr	NN	I-NP	O
after	after	IN	B-PP	O
-RRB-	-RRB-	NN	B-NP	B-protein
Take	Take	NN	I-NP	I-protein
2	2	CD	B-NP	I-protein
hours	hour	NNS	I-NP	I-protein
before	before	IN	B-PP	O
or	or	CC	B-NP	O
2	2	CD	I-NP	O
hours	hour	NNS	I-NP	O
after	after	IN	B-PP	O
dairy	dairy	NN	B-NP	O
products	product	NNS	I-NP	O
.	.	.	O	O

DEPAKOTE	DEPAKOTE	NN	B-NP	O
-LRB-	-LRB-	NN	I-NP	O
DIVALPROEX	DIVALPROEX	NN	I-NP	O
SODIUM	SODIUM	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
750	750	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/12	10/12	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
COLACE	COLACE	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
DOCUSATE	DOCUSATE	NNP	I-NP	O
SODIUM	SODIUM	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
100	100	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BID	BID	NNP	I-NP	O
NEXIUM	NEXIUM	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
ESOMEPRAZOLE	ESOMEPRAZOLE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
20	20	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
PROZAC	PROZAC	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
FLUOXETINE	FLUOXETINE	NN	I-NP	O
HCL	HCL	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
30	30	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
LASIX	LASIX	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
FUROSEMIDE	FUROSEMIDE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
40	40	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
DAILY	DAILY	NNP	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
NEURONTIN	NEURONTIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
GABAPENTIN	GABAPENTIN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
300	300	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
TID	TID	NNP	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
7/18	7/18	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
MOTRIN	MOTRIN	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
IBUPROFEN	IBUPROFEN	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
600	600	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q6H	Q6H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Take	Take	NNP	I-NP	O
with	with	IN	B-PP	O
food	food	NN	B-NP	O
INSULIN	INSULIN	NN	I-NP	O
70/30	70/30	CD	I-NP	O
HUMAN	HUMAN	NN	I-NP	O
20	20	CD	B-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QAM	QAM	NNP	I-NP	O
INSULIN	INSULIN	NNP	I-NP	O
70/30	70/30	CD	I-NP	O
HUMAN	HUMAN	NNP	I-NP	O
15	15	CD	I-NP	O
UNITS	UNITS	NNP	I-NP	O
SC	SC	NNP	I-NP	O
QPM	QPM	NNP	I-NP	O
IMDUR	IMDUR	NNP	I-NP	O
ER	ER	NN	I-NP	B-protein
-LRB-	-LRB-	NNP	I-NP	O
ISOSORBIDE	ISOSORBIDE	NNP	I-NP	O
MONONITRATE	MONONITRATE	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
SR	SR	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
30	30	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
HOLD	HOLD	NN	I-NP	O
IF	IF	NN	I-NP	O
:	:	:	O	O
SBP	SBP	NN	B-NP	B-protein
<	<	SYM	O	O
100	100	CD	B-NP	O
Food/Drug	Food/Drug	NN	I-NP	O
Interaction	Interaction	NN	I-NP	O
Instruction	Instruction	NN	I-NP	O
Give	Give	NN	I-NP	O
on	on	IN	B-PP	O
an	an	DT	B-NP	O
empty	empty	JJ	I-NP	O
stomach	stomach	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
give	give	VBP	B-VP	O
1hr	1hr	NN	B-NP	O
before	before	IN	B-SBAR	O
or	or	CC	O	O
2hr	2hr	NN	B-NP	O
after	after	IN	B-PP	O
food	food	NN	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
LACTULOSE	LACTULOSE	NN	I-NP	O
15-30	15-30	CD	I-NP	O
MILLILITERS	MILLILITERS	NNP	I-NP	O
PO	PO	NNP	I-NP	O
QID	QID	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Constipation	Constipation	NNP	I-NP	O
LIDODERM	LIDODERM	NNP	I-NP	O
5	5	CD	I-NP	O
%	%	NN	I-NP	O
PATCH	PATCH	NN	I-NP	O
-LRB-	-LRB-	SYM	B-NP	O
LIDOCAINE	LIDOCAINE	NN	I-NP	O
5	5	CD	B-NP	O
%	%	NN	I-NP	O
PATCH	PATCH	NN	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
TOPICAL	TOPICAL	NN	I-NP	O
TP	TP	NN	I-NP	O
DAILY	DAILY	NN	I-NP	O
Instructions	Instruction	NNS	I-NP	O
:	:	:	O	O
apply	apply	VB	B-VP	O
to	to	TO	B-PP	O
painful	painful	JJ	B-NP	O
area	area	NN	I-NP	O
as	as	IN	B-SBAR	O
directed	direct	VBN	B-VP	O
by	by	IN	B-PP	O
patient	patient	NN	B-NP	O
ZYPREXA	ZYPREXA	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OLANZAPINE	OLANZAPINE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
15	15	CD	I-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Number	Number	NNP	I-NP	O
of	of	IN	B-PP	O
Doses	Doses	NNP	B-NP	O
Required	Required	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
approximate	approximate	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
:	:	:	O	O
6	6	CD	B-NP	O
OXYCODONE	OXYCODONE	NN	I-NP	O
5-10	5-10	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
Q4H	Q4H	NNP	I-NP	O
PRN	PRN	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
HOLD	HOLD	NNP	I-NP	O
IF	IF	NNP	I-NP	O
:	:	:	O	O
RR	RR	NN	B-NP	B-protein
<	<	JJR	I-NP	I-protein
10	10	CD	I-NP	I-protein
or	or	CC	I-NP	O
hypersomnolence	hypersomnolence	NN	I-NP	O
OXYCONTIN	OXYCONTIN	NN	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
OXYCODONE	OXYCODONE	NNP	I-NP	O
CONTROLLED	CONTROLLED	NNP	I-NP	O
RELEASE	RELEASE	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
10	10	CD	I-NP	O
MG	MG	NN	I-NP	O
PO	PO	NN	I-NP	O
Q12H	Q12H	NN	I-NP	O
Starting	Starting	NNP	I-NP	O
Today	Today	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
10/12	10/12	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
HOLD	HOLD	NN	I-NP	B-protein
IF	IF	NN	I-NP	I-protein
:	:	:	O	O
RR	RR	NN	B-NP	B-protein
<	<	JJR	I-NP	I-protein
10	10	CD	I-NP	I-protein
or	or	CC	I-NP	O
hypersomnolence	hypersomnolence	NN	I-NP	O
SENNA	SENNA	NN	I-NP	O
TABLETS	TABLETS	NN	I-NP	O
-LRB-	-LRB-	HYPH	B-NP	O
SENNOSIDES	SENNOSIDES	NN	I-NP	B-protein
-RRB-	-RRB-	HYPH	B-NP	I-protein
2	2	CD	I-NP	I-protein
TAB	TAB	NN	I-NP	I-protein
PO	PO	NN	I-NP	I-protein
BID	BID	NN	I-NP	I-protein
ZOCOR	ZOCOR	NN	I-NP	I-protein
-LRB-	-LRB-	NN	I-NP	I-protein
SIMVASTATIN	SIMVASTATIN	NN	I-NP	I-protein
-RRB-	-RRB-	,	O	O
40	40	CD	B-NP	O
MG	MG	NNP	I-NP	O
PO	PO	NNP	I-NP	O
BEDTIME	BEDTIME	NNP	I-NP	O
Food/Drug	Food/Drug	NNP	I-NP	O
Interaction	Interaction	NNP	I-NP	O
Instruction	Instruction	NNP	I-NP	O
Avoid	Avoid	NNP	I-NP	O
grapefruit	grapefruit	NN	I-NP	O
unless	unless	IN	B-SBAR	O
MD	MD	NN	B-NP	O
instructs	instruct	NNS	I-NP	O
otherwise	otherwise	RB	B-ADVP	O
.	.	.	O	O

DIET	DIET	NN	B-NP	O
:	:	:	O	O
House	House	NNP	B-NP	O
/	/	SYM	B-NP	O
Low	Low	JJ	I-NP	O
chol/low	chol/low	NN	I-NP	O
sat	sat	NN	I-NP	O
.	.	.	O	O

fat	fat	JJ	B-NP	O
DIET	DIET	NN	I-NP	O
:	:	:	O	O
House	House	NN	B-NP	O
/	/	SYM	O	O
ADA	ADA	NN	B-NP	O
1800	1800	CD	I-NP	O
cals/dy	cals/dy	NN	I-NP	O
RETURN	RETURN	NNP	I-NP	O
TO	TO	NNP	I-NP	O
WORK	WORK	NNP	I-NP	O
:	:	:	O	O
Not	Not	NNP	B-NP	O
Applicable	Applicable	NNP	I-NP	O
FOLLOW	FOLLOW	NNP	I-NP	O
UP	UP	NNP	I-NP	O
APPOINTMENT	APPOINTMENT	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
S	S	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
:	:	:	O	O
Ortho	Ortho	NNP	B-NP	O
Dr	Dr	NNP	I-NP	O
Chesley	Chesley	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
105	105	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
529-3631	529-3631	CD	I-NP	O
7/25/06	7/25/06	CD	I-NP	O
@	@	NN	I-NP	O
12	12	CD	I-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
Pain	Pain	NNP	B-NP	O
clinic	clinic	NN	I-NP	O
Dr	Dr	NNP	I-NP	O
Gobler	Gobler	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
749	749	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
684-6883	684-6883	CD	I-NP	O
10/22/06	10/22/06	CD	I-NP	O
@	@	NN	I-NP	O
10	10	CD	I-NP	O
:	:	:	O	O
45	45	CD	B-NP	O
am	am	NN	I-NP	O
,	,	,	O	O
Renaldo	Renaldo	NNP	B-NP	O
Trischitta	Trischitta	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
128	128	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
883-9670	883-9670	CD	I-NP	O
10/15/06	10/15/06	CD	I-NP	O
@	@	SYM	B-NP	O
1	1	CD	I-NP	O
:	:	SYM	I-NP	O
00	00	CD	I-NP	O
pm	pm	NN	I-NP	O
,	,	,	O	O
ALLERGY	ALLERGY	NN	B-NP	O
:	:	:	O	O
benadryl	benadryl	NN	B-NP	O
,	,	,	O	O
haldol	haldol	NN	B-NP	O
ADMIT	ADMIT	NN	I-NP	O
DIAGNOSIS	DIAGNOSIS	NN	I-NP	O
:	:	:	O	O
Syncope	Syncope	NNP	B-NP	O
PRINCIPAL	PRINCIPAL	NNP	I-NP	O
DISCHARGE	DISCHARGE	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Responsible	Responsible	JJ	B-ADJP	O
After	After	IN	B-PP	O
Study	Study	NNP	B-NP	O
for	for	IN	B-PP	O
Causing	Causing	NNP	B-NP	O
Admission	Admission	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Vertiginous	Vertiginous	NNP	I-NP	O
fall	fall	NNP	I-NP	O
OTHER	OTHER	NNP	I-NP	O
DIAGNOSIS	DIAGNOSIS	NNP	I-NP	O
;	;	:	O	O
Conditions	Condition	NNS	B-NP	O
,	,	,	O	O
Infections	Infection	NNS	B-NP	O
,	,	,	O	O
Complications	Complication	NNS	B-NP	O
,	,	,	O	O
affecting	affect	VBG	B-VP	O
Treatment/Stay	Treatment/Stay	NNP	B-NP	O
DM	DM	NNP	I-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
HL	HL	NN	B-NP	O
,	,	,	O	O
Bipolar	Bipolar	NNP	B-NP	O
,	,	,	O	O
Epilepsy	Epilepsy	NNP	B-NP	O
,	,	,	O	O
L	L	NNP	B-NP	O
knee	knee	VBP	B-VP	O
arthroplasty	arthroplasty	JJ	B-ADJP	O
for	for	IN	B-PP	O
septic	septic	JJ	B-NP	O
knee	knee	NN	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
9/21	9/21	CD	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
,	,	,	O	O
Bilat	Bilat	NNP	B-NP	O
TKR	TKR	NNP	I-NP	O
,	,	,	O	O
CAD	CAD	NNP	B-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NNP	B-NP	O
2003	2003	CD	I-NP	O
OPERATIONS	OPERATIONS	NNS	I-NP	O
AND	AND	CC	I-NP	O
PROCEDURES	PROCEDURES	NNS	I-NP	O
:	:	:	O	O
none	none	NN	B-NP	O
OTHER	OTHER	NN	I-NP	O
TREATMENTS/PROCEDURES	TREATMENTS/PROCEDURES	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
NOT	NOT	NNP	I-NP	O
IN	IN	NNP	I-NP	O
O.R.	O.R.	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
none	none	NN	I-NP	O
BRIEF	BRIEF	NN	I-NP	O
RESUME	RESUME	NN	I-NP	O
OF	OF	IN	B-PP	O
HOSPITAL	HOSPITAL	JJ	B-NP	O
COURSE	COURSE	NN	I-NP	O
:	:	:	O	O
CC	CC	NN	B-NP	O
:	:	:	O	O
Yall	Yall	NN	B-NP	O
,	,	,	O	O
w/u	w/u	NN	B-NP	O
for	for	IN	B-PP	O
syncope	syncope	NN	B-NP	O
**	**	SYM	I-NP	O
HPI	HPI	NN	I-NP	O
:	:	:	O	O
46F	46F	NN	B-NP	O
with	with	IN	B-PP	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
CAD	CAD	NN	B-NP	B-protein
,	,	,	O	O
epilepsy	epilepsy	NN	B-NP	O
and	and	CC	O	O
bilateral	bilateral	JJ	B-NP	O
knee	knee	NN	I-NP	O
operations	operation	NNS	I-NP	O
who	who	WP	B-NP	O
felt	feel	VBD	B-VP	O
vertiginous	vertiginous	JJ	B-ADJP	O
and	and	CC	O	O
fell	fall	VBD	B-VP	O
while	while	IN	B-SBAR	O
transferring	transfer	VBG	B-VP	O
from	from	IN	B-PP	O
wheechair	wheechair	NN	B-NP	O
to	to	TO	B-VP	O
toilet	toilet	VB	I-VP	O
,	,	,	O	O
hurting	hurt	VBG	B-VP	O
her	her	PRP$	B-NP	O
left	left	JJ	I-NP	O
knee	knee	NN	I-NP	O
,	,	,	O	O
which	which	WDT	B-NP	O
according	accord	VBG	B-PP	O
to	to	TO	B-PP	O
ortho	ortho	JJ	B-NP	O
has	have	VBZ	B-VP	O
an	an	DT	B-NP	O
old	old	JJ	I-NP	O
fracture	fracture	NN	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
had	have	VBD	B-VP	O
not	not	RB	I-VP	O
felt	feel	VBN	I-VP	O
well	well	RB	B-ADVP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
few	few	JJ	I-NP	O
days	day	NNS	I-NP	O
,	,	,	O	O
hot	hot	JJ	B-NP	O
and	and	CC	I-NP	O
cold	cold	JJ	I-NP	O
flashes	flash	NNS	I-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
took	take	VBD	B-VP	O
her	her	PRP$	B-NP	O
insulin	insulin	NN	I-NP	B-protein
and	and	CC	O	O
other	other	JJ	B-NP	O
meds	med	NNS	I-NP	O
30	30	CD	B-NP	O
minutes	minute	NNS	I-NP	O
prior	prior	RB	B-ADVP	O
to	to	TO	B-PP	O
the	the	DT	B-NP	O
episode	episode	NN	I-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
CP/SOB	CP/SOB	NN	I-NP	B-protein
,	,	,	O	O
no	no	DT	B-NP	O
LOC	LOC	NN	I-NP	B-protein
.	.	.	O	O

**	**	SYM	B-NP	O
PMH	PMH	NN	I-NP	O
:	:	:	O	O
DM	DM	NN	B-NP	O
,	,	,	O	O
HTN	HTN	NN	B-NP	B-protein
,	,	,	O	O
HL	HL	NN	B-NP	O
,	,	,	O	O
Bipolar	Bipolar	NNP	B-NP	O
,	,	,	O	O
Epilepsy	Epilepsy	NNP	B-NP	O
,	,	,	O	O
L	L	NNP	B-NP	O
knee	knee	VBP	B-VP	O
arthroplasty	arthroplasty	JJ	B-ADJP	O
for	for	IN	B-PP	O
septic	septic	JJ	B-NP	O
knee	knee	NN	I-NP	O
-LRB-	-LRB-	HYPH	O	O
9/21	9/21	CD	B-NP	O
-RRB-	-RRB-	NN	I-NP	O
,	,	,	O	O
bilat	bilat	NN	B-NP	O
TKR	TKR	NNP	B-NP	O
,	,	,	O	O
CAD	CAD	NNP	B-NP	O
s/p	s/p	NN	I-NP	O
MI	MI	NNP	I-NP	O
-LRB-	-LRB-	NNP	I-NP	O
2003	2003	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
**	**	SYM	B-NP	O
ALL	ALL	NN	I-NP	O
:	:	:	O	O
Haldol	Haldol	NNP	B-NP	O
**	**	NNP	I-NP	O
Admit	Admit	NNP	I-NP	O
Data	Data	NNP	I-NP	O
:	:	:	O	O
VS	VS	NNP	B-NP	O
:	:	:	O	O
96.8	96.8	CD	B-NP	O
89130/80	89130/80	CD	I-NP	O
16	16	CD	I-NP	O
97	97	CD	I-NP	O
%	%	NN	I-NP	O
RA	RA	NN	I-NP	O
PE	PE	NN	I-NP	O
:	:	:	O	O
NAD	NAD	NN	B-NP	O
,	,	,	O	O
obese	obese	NN	B-NP	O
,	,	,	O	O
NCAT	NCAT	NN	B-NP	B-protein
,	,	,	O	O
CTAB	CTAB	NN	B-NP	B-protein
,	,	,	O	O
RRR	RRR	NN	B-NP	B-protein
c	c	NN	I-NP	I-protein
2/6	2/6	CD	I-NP	I-protein
SM	SM	NN	I-NP	I-protein
,	,	,	O	O
abd	abd	NN	B-NP	O
benign	benign	JJ	B-ADJP	O
,	,	,	O	O
L	L	NN	B-NP	O
knee	knee	NN	I-NP	O
tender	tender	NN	I-NP	O
c	c	NN	I-NP	O
large	large	JJ	I-NP	O
effusion	effusion	NN	I-NP	O
,	,	,	O	O
1	1	CD	B-NP	O
+	+	SYM	I-NP	O
bl	bl	NN	I-NP	O
edema	edema	NN	I-NP	O
Lab	Lab	NN	I-NP	O
:	:	:	O	O
BMP	BMP	NN	B-NP	O
wnl	wnl	NN	I-NP	O
,	,	,	O	O
WBC	WBC	NNP	B-NP	B-cell_line
6.8	6.8	CD	I-NP	I-cell_line
,	,	,	O	O
Hct	Hct	NN	B-NP	B-protein
35.1	35.1	CD	I-NP	I-protein
,	,	,	O	O
biomarkers	biomarker	NNS	B-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
INR	INR	NN	B-NP	B-protein
7.3	7.3	CD	I-NP	I-protein
,	,	,	O	O
U/A	U/A	NN	B-NP	O
neg	neg	NN	I-NP	O
Studies	Study	NNS	I-NP	O
:	:	:	O	O
CT	CT	NN	B-NP	O
head	head	NN	I-NP	O
neg	neg	NN	I-NP	O
,	,	,	O	O
CXR	CXR	NN	B-NP	B-protein
R	R	NN	I-NP	O
base	base	NN	I-NP	O
atelectasis	atelectasis	NN	I-NP	O
,	,	,	O	O
EKG	EKG	NNP	B-NP	O
old	old	JJ	I-NP	O
LBBB	LBBB	NNP	I-NP	O
,	,	,	O	O
Knee	Knee	NNP	B-NP	O
XR	XR	NNP	I-NP	O
L	L	NNP	I-NP	O
knee	knee	NN	I-NP	O
fracture	fracture	NN	I-NP	O
through	through	IN	B-PP	O
cement	cement	NN	B-NP	O
spacer	spacer	NN	I-NP	O
and	and	CC	O	O
tibial	tibial	JJ	B-NP	B-protein
stem	stem	NN	I-NP	I-protein
**	**	SYM	B-NP	I-protein
1	1	CD	I-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
CV	CV	NN	I-NP	O
-	-	HYPH	O	O
-LSB-	-LSB-	SYM	O	O
I	I	PRP	B-NP	O
-RSB-	-RSB-	SYM	B-NP	O
Ruled	Rule	VBD	B-VP	O
out	out	RP	B-PRT	O
with	with	IN	B-PP	O
enzymes	enzyme	NNS	B-NP	B-protein
negative	negative	JJ	B-NP	I-protein
x3	x3	NN	I-NP	I-protein
,	,	,	O	O
LBBB	LBBB	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
old	old	JJ	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
on	on	IN	B-PP	O
EKG	EKG	NN	B-NP	B-protein
.	.	.	O	O

Cont	Cont	NNP	B-NP	O
ASA	ASA	NNP	I-NP	O
,	,	,	O	O
statin	statin	NN	B-NP	O
,	,	,	O	O
BB	BB	NN	B-NP	B-protein
,	,	,	O	O
nitrate	nitrate	NN	B-NP	O
.	.	.	O	O

No	No	DT	B-NP	O
complaints	complaint	NNS	I-NP	O
of	of	IN	B-PP	O
chest	chest	NN	B-NP	O
discomfort	discomfort	NN	I-NP	O
.	.	.	O	O

-LSB-	-LSB-	NN	B-NP	O
P	P	NN	I-NP	O
-RSB-	-RSB-	NN	I-NP	O
HTN	HTN	NN	I-NP	O
,	,	,	O	O
euvolemic	euvolemic	JJ	B-ADJP	O
,	,	,	O	O
continued	continue	VBD	B-VP	O
BB	BB	NNP	B-NP	O
,	,	,	O	O
nitrate	nitrate	NN	B-NP	O
.	.	.	O	O

Echo	Echo	NNP	B-NP	O
showed	show	VBD	B-VP	O
normal	normal	JJ	B-NP	O
EF	EF	NN	I-NP	O
55-60	55-60	CD	B-NP	O
%	%	NN	I-NP	O
and	and	CC	O	O
no	no	DT	B-NP	O
structural	structural	JJ	I-NP	O
or	or	CC	I-NP	O
valvular	valvular	JJ	I-NP	O
abnormalities	abnormality	NNS	I-NP	O
.	.	.	O	O

-LSB-	-LSB-	JJ	B-NP	B-protein
R	R	NN	I-NP	I-protein
-RSB-	-RSB-	NN	I-NP	I-protein
NSR	NSR	NN	I-NP	I-protein
on	on	IN	B-PP	O
telemetry	telemetry	NN	B-NP	O
.	.	.	O	O

2	2	CD	B-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Neuro	Neuro	NN	I-NP	B-protein
-	-	HYPH	B-NP	O
doubt	doubt	NN	I-NP	O
seizure	seizure	NN	I-NP	O
with	with	IN	B-PP	O
no	no	DT	B-NP	O
loss	loss	NN	I-NP	O
of	of	IN	B-PP	O
consciousness	consciousness	NN	B-NP	O
,	,	,	O	O
depakote	depakote	NN	B-NP	O
level	level	NN	I-NP	O
low	low	JJ	I-NP	O
-LRB-	-LRB-	NN	I-NP	O
32	32	CD	I-NP	O
,	,	,	O	O
therapeutic	therapeutic	JJ	B-NP	O
range	range	NN	I-NP	O
50-100	50-100	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

Will	Will	MD	B-VP	O
increase	increase	VB	I-VP	O
dose	dose	NN	B-NP	O
to	to	TO	B-PP	O
750mg	750mg	CD	B-NP	O
bid	bid	NN	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
recheck	recheck	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

3	3	CD	B-NP	O
-RRB-	-RRB-	HYPH	B-NP	O
Ortho	Ortho	AFX	I-NP	B-DNA
-	-	HYPH	I-NP	O
ortho	ortho	JJ	I-NP	O
consulted	consult	VBN	B-VP	O
,	,	,	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
f/u	f/u	NN	B-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
for	for	IN	B-PP	O
surgery	surgery	NN	B-NP	O
4	4	CD	I-NP	O
-RRB-	-RRB-	HYPH	I-NP	O
Heme	Heme	NN	I-NP	B-protein
-	-	HYPH	B-ADJP	O
on	on	IN	B-PP	O
coumadin	coumadin	NN	B-NP	O
after	after	IN	B-PP	O
surgery	surgery	NN	B-NP	O
in	in	IN	B-PP	O
9/21	9/21	CD	B-NP	O
,	,	,	O	O
should	should	MD	B-VP	O
have	have	VB	I-VP	O
stopped	stop	VBN	I-VP	O
taking	take	VBG	I-VP	O
it	it	PRP	B-NP	O
.	.	.	O	O

INR	INR	NN	B-NP	O
7.3	7.3	CD	I-NP	O
on	on	IN	B-PP	O
admission	admission	NN	B-NP	O
so	so	RB	B-VP	O
holding	hold	VBG	I-VP	O
all	all	DT	B-NP	O
anticoagulation	anticoagulation	NN	I-NP	B-protein
5	5	CD	I-NP	I-protein
-RRB-	-RRB-	NN	I-NP	I-protein
Prophy	Prophy	NN	I-NP	O
:	:	:	O	O
hold	hold	VB	B-VP	O
DVT	DVT	NN	B-NP	O
prophy	prophy	NN	I-NP	O
for	for	IN	B-PP	O
now	now	RB	B-NP	O
given	give	VBN	I-NP	O
INR	INR	NN	B-NP	B-protein
,	,	,	O	O
ppi	ppi	NN	B-NP	B-protein
6	6	CD	I-NP	I-protein
-RRB-	-RRB-	NNP	I-NP	O
Pain	Pain	NNP	I-NP	O
:	:	:	O	O
nightly	nightly	RB	B-ADVP	O
has	have	VBZ	B-VP	O
10	10	CD	B-NP	O
second	second	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
apnea	apnea	NN	B-NP	O
,	,	,	O	O
snoring	snoring	NN	B-NP	O
,	,	,	O	O
bradypnea	bradypnea	NN	B-NP	O
to	to	TO	B-PP	O
6-8	6-8	CD	B-NP	O
/	/	SYM	O	O
min	min	NN	B-NP	O
with	with	IN	B-PP	O
O2	O2	NN	B-NP	O
desats	desat	NNS	I-NP	O
to	to	TO	B-VP	O
mid	mid	VB	I-VP	O
80	80	CD	B-NP	O
's	's	POS	B-NP	O
on	on	IN	B-PP	O
RA	RA	NN	B-NP	B-protein
.	.	.	O	O

Could	Could	MD	B-VP	O
be	be	VB	I-VP	O
oversedation	oversedation	NN	B-NP	O
with	with	IN	B-PP	O
narcotics	narcotic	NNS	B-NP	O
though	though	IN	B-SBAR	O
she	she	PRP	B-NP	O
exhibited	exhibit	VBD	B-VP	O
these	these	DT	B-NP	O
episodes	episode	NNS	I-NP	O
even	even	RB	B-ADVP	O
when	when	WRB	I-ADVP	O
holding	hold	VBG	B-VP	O
narcs	narc	NNS	B-NP	O
,	,	,	O	O
so	so	RB	B-ADJP	O
more	more	RBR	B-NP	O
likely	likely	JJ	I-NP	O
Pickwickian	Pickwickian	JJ	I-NP	O
syndrome	syndrome	NN	I-NP	O
,	,	,	O	O
will	will	MD	B-VP	O
need	need	VB	I-VP	O
a	a	DT	B-NP	O
sleep	sleep	JJ	I-NP	O
study	study	NN	I-NP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
.	.	.	O	O

She	She	PRP	B-NP	O
continues	continue	VBZ	B-VP	O
to	to	TO	I-VP	O
complain	complain	VB	I-VP	O
of	of	IN	B-PP	O
8/10	8/10	CD	B-NP	O
pain	pain	NN	I-NP	O
even	even	RB	B-ADVP	O
on	on	IN	B-PP	O
her	her	PRP$	B-NP	O
home	home	NN	I-NP	O
regimen	regimen	NN	I-NP	O
of	of	IN	B-PP	O
oxycontin/oxycodone	oxycontin/oxycodone	NN	B-NP	O
,	,	,	O	O
so	so	IN	O	O
we	we	PRP	B-NP	O
tried	try	VBD	B-VP	O
adding	add	VBG	I-VP	O
dilaudid	dilaudid	NN	B-NP	O
and	and	CC	I-NP	O
morphin	morphin	NN	I-NP	O
IR	IR	NN	I-NP	O
for	for	IN	B-PP	O
breakthrough	breakthrough	NN	B-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

Due	Due	JJ	B-ADJP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
apneic	apneic	JJ	I-NP	O
episodes	episode	NNS	I-NP	O
and	and	CC	O	O
the	the	DT	B-NP	O
fact	fact	NN	I-NP	O
that	that	IN	B-SBAR	O
she	she	PRP	B-NP	O
has	have	VBZ	B-VP	O
not	not	RB	I-VP	O
moved	move	VBN	I-VP	O
her	her	PRP$	B-NP	O
bowels	bowel	NNS	I-NP	O
since	since	IN	B-PP	O
admission	admission	NN	B-NP	O
we	we	PRP	B-NP	O
stopped	stop	VBD	B-VP	O
these	these	DT	B-NP	O
and	and	CC	O	O
decreased	decrease	VBD	B-VP	O
her	her	PRP$	B-NP	O
oxycontin	oxycontin	NN	I-NP	O
by	by	IN	B-PP	O
half	half	NN	B-NP	O
to	to	TO	B-PP	O
10mg	10mg	CD	B-NP	O
bid	bid	NN	I-NP	O
.	.	.	O	O

Per	Per	NN	B-NP	B-cell_type
pain	pain	NN	I-NP	I-cell_type
service	service	NN	I-NP	I-cell_type
recs	rec	NNS	I-NP	I-cell_type
,	,	,	O	O
we	we	PRP	B-NP	O
discontinued	discontinue	VBD	B-VP	O
trazadone	trazadone	NN	B-NP	O
and	and	CC	O	O
added	add	VBN	B-VP	O
neurontin	neurontin	NN	B-NP	B-protein
,	,	,	O	O
as	as	IN	B-SBAR	O
trazodone	trazodone	NN	B-NP	O
could	could	MD	B-VP	O
be	be	VB	I-VP	O
contributing	contribute	VBG	I-VP	O
to	to	TO	B-PP	O
her	her	PRP$	B-NP	O
daily	daily	JJ	I-NP	O
drowsiness	drowsiness	NN	I-NP	O
,	,	,	O	O
and	and	CC	O	O
neurontin	neurontin	NN	B-NP	B-protein
may	may	MD	B-VP	O
help	help	VB	I-VP	O
with	with	IN	B-PP	O
her	her	PRP$	B-NP	O
chronic	chronic	JJ	I-NP	O
pain	pain	NN	I-NP	O
.	.	.	O	O

On	On	IN	B-PP	O
discharge	discharge	NN	B-NP	O
,	,	,	O	O
we	we	PRP	B-NP	O
will	will	MD	B-VP	O
not	not	RB	I-VP	O
add	add	VB	I-VP	O
any	any	DT	B-NP	O
new	new	JJ	I-NP	O
narcotics	narcotic	NNS	I-NP	O
.	.	.	O	O

F/u	F/u	NN	B-NP	O
pain	pain	NN	I-NP	O
service	service	NN	I-NP	O
as	as	IN	B-PP	O
outpt	outpt	NN	B-NP	O
.	.	.	O	O

7	7	CD	B-NP	O
-RRB-	-RRB-	NNP	I-NP	O
Dispo	Dispo	NNP	I-NP	O
:	:	:	O	O
PT	PT	NN	B-NP	O
consulted	consult	VBD	B-VP	O
for	for	IN	B-PP	O
possible	possible	JJ	B-NP	O
rehab	rehab	NN	I-NP	O
placement	placement	NN	I-NP	O
8	8	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
ID	ID	NN	I-NP	O
:	:	:	O	O
spiked	spike	VBN	B-VP	O
to	to	TO	B-PP	O
101.2	101.2	CD	B-NP	O
on	on	IN	B-PP	O
7/18	7/18	CD	B-NP	O
,	,	,	O	O
UA	UA	NNP	B-NP	O
shows	show	VBZ	B-VP	O
likely	likely	JJ	B-NP	O
UTI	UTI	NNP	I-NP	O
,	,	,	O	O
awaiting	await	VBG	B-VP	O
cx	cx	NN	B-NP	O
's	's	POS	B-NP	O
,	,	,	O	O
treating	treat	VBG	B-VP	O
empirically	empirically	RB	B-ADVP	O
with	with	IN	B-PP	O
cipro	cipro	NN	B-NP	B-protein
500	500	CD	I-NP	I-protein
po	po	NN	I-NP	I-protein
bid	bid	NN	I-NP	I-protein
x	x	SYM	B-VP	I-protein
7	7	CD	B-NP	I-protein
days	day	NNS	I-NP	I-protein
9	9	CD	B-NP	I-protein
-RRB-	-RRB-	HYPH	I-NP	O
Full	Full	NNP	I-NP	O
Code	Code	NNP	I-NP	O
ADDITIONAL	ADDITIONAL	NNP	I-NP	O
COMMENTS	COMMENTS	NNP	I-NP	O
:	:	:	O	O
You	You	PRP	B-NP	B-protein
will	will	MD	B-VP	O
be	be	VB	I-VP	O
discharged	discharge	VBN	I-VP	O
to	to	TO	B-PP	O
a	a	DT	B-NP	O
rehabilitation	rehabilitation	NN	I-NP	O
facility	facility	NN	I-NP	O
.	.	.	O	O

Please	Please	VB	B-VP	O
seek	seek	VB	I-VP	O
medical	medical	JJ	B-NP	O
attention	attention	NN	I-NP	O
if	if	IN	B-SBAR	O
you	you	PRP	B-NP	O
have	have	VBP	B-VP	O
any	any	DT	B-NP	O
episodes	episode	NNS	I-NP	O
of	of	IN	B-PP	O
fainting	faint	VBG	B-NP	O
.	.	.	O	O

DISCHARGE	DISCHARGE	NN	B-NP	O
CONDITION	CONDITION	NN	I-NP	O
:	:	:	O	O
Stable	Stable	JJ	B-NP	O
TO	TO	NN	I-NP	O
DO/PLAN	DO/PLAN	NN	I-NP	O
:	:	:	O	O
-	-	HYPH	B-NP	O
continue	continue	JJ	I-NP	O
ciprofloxacin	ciprofloxacin	NN	I-NP	O
for	for	IN	B-PP	O
7	7	CD	B-NP	O
days	day	NNS	I-NP	O
for	for	IN	B-PP	O
UTI	UTI	NN	B-NP	B-protein
-	-	HYPH	O	O
increased	increase	VBN	B-NP	O
dose	dose	NN	I-NP	O
of	of	IN	B-PP	O
valproic	valproic	JJ	B-NP	O
acid	acid	NN	I-NP	O
from	from	IN	B-PP	O
500mg	500mg	CD	B-NP	O
bid	bid	NN	I-NP	O
to	to	TO	B-VP	O
750mg	750mg	VB	I-VP	O
bid	bid	NN	B-NP	O
for	for	IN	B-PP	O
a	a	DT	B-NP	O
subtherapeutic	subtherapeutic	JJ	I-NP	O
level	level	NN	I-NP	O
of	of	IN	B-PP	O
32	32	CD	B-NP	O
-LRB-	-LRB-	SYM	I-NP	O
goal	goal	NN	I-NP	O
50-100	50-100	CD	I-NP	O
-RRB-	-RRB-	NN	I-NP	O
.	.	.	O	O

will	will	MD	B-VP	O
need	need	VB	I-VP	O
this	this	DT	B-NP	O
rechecked	rechecke	VBN	B-VP	O
as	as	IN	B-PP	O
outpatient	outpatient	NN	B-NP	O
-	-	HYPH	O	O
f/u	f/u	NN	B-NP	O
with	with	IN	B-PP	O
orthopedics	orthopedic	NNS	B-NP	O
re	re	NN	I-NP	O
:	:	:	O	O
L	L	NN	B-NP	O
knee	knee	NN	I-NP	O
fracture	fracture	NN	I-NP	O
-	-	HYPH	B-NP	O
f/u	f/u	NN	I-NP	O
with	with	IN	B-PP	O
pain	pain	NN	B-NP	O
clinic	clinic	NN	I-NP	O
re	re	NN	I-NP	O
:	:	:	O	O
chronic	chronic	JJ	B-NP	O
pain	pain	NN	I-NP	O
-	-	HYPH	B-NP	O
f/u	f/u	NN	I-NP	O
with	with	IN	B-PP	O
PCP	PCP	NN	B-NP	O
Levi	Levi	NNP	I-NP	O
Riccio	Riccio	NNP	I-NP	O
,	,	,	O	O
may	may	MD	B-VP	O
need	need	VB	I-VP	O
outpt	outpt	JJ	B-NP	O
sleep	sleep	NN	I-NP	O
study	study	NN	I-NP	O
for	for	IN	B-PP	O
obesity	obesity	NN	B-NP	O
hypoventilation	hypoventilation	NN	I-NP	O
syndrome	syndrome	NN	I-NP	O
No	No	DT	B-NP	O
dictated	dictated	JJ	I-NP	O
summary	summary	NN	I-NP	O
ENTERED	ENTERED	NNP	I-NP	O
BY	BY	NNP	I-NP	O
:	:	:	O	O
NAREZ	NAREZ	NNP	B-NP	O
,	,	,	O	O
GALEN	GALEN	NNP	B-NP	O
R.	R.	NNP	I-NP	O
,	,	,	O	O
M.D.	M.D.	NNP	B-NP	O
-LRB-	-LRB-	NNP	I-NP	O
AV66	AV66	NNP	I-NP	O
-RRB-	-RRB-	NNP	I-NP	O
11/24/06	11/24/06	CD	I-NP	O
@	@	SYM	B-NP	O
11	11	CD	I-NP	O
******	******	SYM	I-NP	O
END	END	NN	I-NP	O
OF	OF	IN	B-PP	O
DISCHARGE	DISCHARGE	NN	B-NP	O
ORDERS	ORDERS	NNS	I-NP	O
******	******	SYM	B-NP	O

